Well-Being and Health-Related Quality of Life in Melanoma Patients During COVID-19 Pandemic
Ориентир для пациента и семьи
Простыми словами
Автоматическая сводка по структурированным данным реестра. Она помогает сориентироваться, но не заменяет официальный протокол или оценку врача.
- Что изучают
- В протоколе указаны: Survey Administration.
- Кому может быть актуально
- Состояния в реестре: COVID-19 Infection, Melanoma. Базовые параметры: Без ограничений · Все.
- Что важно проверить
- Возраст, диагноз и пол — только базовые ориентиры. Предыдущее лечение, анализы и другие обязательные условия указаны ниже в критериях участия.
- Где проводится
- США
- Следующий шаг
- Сохраните исследование, покажите его лечащему врачу и уточните актуальный статус у исследовательского центра. Расходы, документы и поездка →
Не всё понятно в терминах? Прочитайте наш гид для пациентов →
Официальное название
Well-Being and Quality of Life in Melanoma Patients During COVID-19 Pandemic
Обзор
The primary purpose of this study is to gain an understanding of how experiences during the COVID-19 pandemic, regardless of COVID-19 status, may have impacted multiple domains of health-related quality of life and other areas such as COVID-19 specific psychological distress, and disruptions to health care, finances and social interactions. We will also evaluate the extent to which resiliency factors such as social support, perceived benefits under times of stress, and ability to manage stress may buffer associations between COVID-19 experiences and HRQoL. To meet these objectives, we have developed a 10-minute questionnaire that taps into these areas and is based on prior work addressing concerns of other pandemics or national crises. Participants will have previously consented to protocol PA15-0336 and have provided prior lifestyle data. This will allow us to connect the COVID-19 survey data with prior existing data.
Подробное описание
PRIMARY OBJECTIVES:
I. Assess experiences during the COVID-19 pandemic (e.g., exposure, risk factors, testing, isolation, seropositivity, hospitalization, loss of family or friends); COVID-19-specific psychological distress (e.g., fear, anxiety and depressive symptoms); health, financial and social disruptions; perceived benefits and social support; and health-related quality of life (HRQoL) in melanoma patients who participated in protocol PA15-0336.
II. Evaluate the extent to which COVID-19 experiences are associated with COVID-19-specific psychological distress, health, financial and social disruptions, perceived benefits and social support, and HRQoL.
III. Evaluate the extent to which resiliency factors such as social support and perceived benefits moderate the effects of COVID-19 experiences on COVID-19-specific psychological distress and HRQoL.
IV. Explore the association between prior lifestyle data collected as part of PA15-0336 and COVID-19-specific psychological distress and HRQoL.
OUTLINE:
Patients complete a survey over 10 minutes.
Вмешательства
- Другое Survey Administration
Complete survey
Первичные конечные точки
- Experiences during the COVID-19 pandemic [Срок оценки: Survey completion Up to 2 months]
- COVID-19-specific psychological distress [Срок оценки: Survey completion Up to 2 months]
- COVID-19-specific health [Срок оценки: Survey completion Up to 2 months]
- COVID-19-specific financial and social disruptions [Срок оценки: Survey completion Up to 2 months]
- COVID-19-specific perceived benefits and social support [Срок оценки: Survey completion Up to 2 months]
- COVID-19-specific health related quality of life (HRQoL) [Срок оценки: Survey completion Up to 2 months]
- Effects of COVID-19 experiences on COVID-19-specific psychological distress and HRQoL [Срок оценки: Survey completion Up to 2 months]
- Prior lifestyle data [Срок оценки: Survey completion Up to 2 months]
Критерии участия
Критерии включения
- Patients who have signed consent for PA15-0336
- Has an active email address and can be contacted via MyChart
- Documentation of being alive per the cancer registry
Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.
Здоровые добровольцы: Нет
Дизайн исследования
- Модель наблюдения
- Только случаи
Центры проведения
США · 1 центр
- M D Anderson Cancer Center — Houston
Идентификаторы
NCT: NCT04474301 · 2020-0470 · NCI-2020-04587 · 2020-0470